K
Kee Sik Kim
Researcher at The Catholic University of America
Publications - 105
Citations - 2071
Kee Sik Kim is an academic researcher from The Catholic University of America. The author has contributed to research in topics: Myocardial infarction & Coronary artery disease. The author has an hindex of 18, co-authored 103 publications receiving 1898 citations. Previous affiliations of Kee Sik Kim include Catholic University College, Kensington & Catholic University of Daegu.
Papers
More filters
Journal ArticleDOI
Duration of Dual Antiplatelet Therapy after Implantation of Drug-Eluting Stents
Seung-Jung Park,Duk-Woo Park,Young-Hak Kim,Soo Jin Kang,Seung-Whan Lee,Cheol Whan Lee,Ki Hoon Han,Seong Wook Park,Sung Cheol Yun,Sang-Gon Lee,Seung-Woon Rha,In Whan Seong,Myung Ho Jeong,Seung Ho Hur,Nae Hee Lee,Junghan Yoon,Joo Young Yang,Bong Ki Lee,Young Jin Choi,Wook Sung Chung,Do-Sun Lim,Sang Sig Cheong,Kee Sik Kim,Jei Keon Chae,Deuk Young Nah,Doo-Soo Jeon,Ki Bae Seung,Jae-Sik Jang,Hun Sik Park,Keun Seok Lee +29 more
TL;DR: The use of dual antiplatelet therapy for a period longer than 12 months in patients who had received drug-eluting stents was not significantly more effective than aspirin monotherapy in reducing the rate of myocardial infarction or death from cardiac causes.
Journal ArticleDOI
Optimal Duration of Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation A Randomized, Controlled Trial
Cheol Whan Lee,Jung-Min Ahn,Duk-Woo Park,Soo Jin Kang,Seung-Whan Lee,Young-Hak Kim,Seong Wook Park,Seungbong Han,Sang-Gon Lee,In Whan Seong,Seung-Woon Rha,Myung Ho Jeong,Do Sun Lim,Jung Han Yoon,Seung Ho Hur,Yun-Seok Choi,Joo Young Yang,Nae Hee Lee,Hyun-Sook Kim,Bong Ki Lee,Kee Sik Kim,Seung Uk Lee,Jei Keon Chae,Sang Sig Cheong,Il Woo Suh,Hun Sik Park,Deuk Young Nah,Doo Soo Jeon,Ki Bae Seung,Keun Hwa Lee,Jae-Sik Jang,Seung-Jung Park +31 more
TL;DR: An additional 24 months of dual antiplatelet therapy versus aspirin alone did not reduce the risk of the composite end point of death from cardiac causes, myocardial infarction, or stroke.
Journal ArticleDOI
Comparison of zotarolimus-eluting stents with sirolimus- and paclitaxel-eluting stents for coronary revascularization: the ZEST (comparison of the efficacy and safety of zotarolimus-eluting stent with sirolimus-eluting and paclitaxel-eluting stent for coronary lesions) randomized trial.
Duk-Woo Park,Young-Hak Kim,Sung Cheol Yun,Soo Jin Kang,Seung-Whan Lee,Cheol Whan Lee,Seong Wook Park,In Whan Seong,Jae-Hwan Lee,Seung-Jea Tahk,Myung Ho Jeong,Yangsoo Jang,Sang Sig Cheong,Joo Young Yang,Do Sun Lim,Ki Bae Seung,Jei Keon Chae,Seung Ho Hur,Sang-Gon Lee,Junghan Yoon,Nae Hee Lee,Young Jin Choi,Hyun-Sook Kim,Kee Sik Kim,Hyo-Soo Kim,Taeg Jong Hong,Hun Sik Park,Seung-Jung Park +27 more
TL;DR: In this large-scale, practical randomized trial, the use of zotarolimus-eluting stent resulted in similar rates of MACE compared with SES and in fewer Mace compared with PES at 12 months.
Journal ArticleDOI
Outcomes of medically treated patients with aortic intramural hematoma.
Jae Kwan Song,Hyun Sook Kim,Jong Min Song,Duk Hyun Kang,Jong-Won Ha,Se-Joong Rim,Namsik Chung,Kee Sik Kim,Seung Woo Park,Kim Yong-Jin,Dae Won Sohn +10 more
TL;DR: Patients with aortic intramural hematoma had a high rate of resorption with medical treatment regardless of the affected site and further investigation is necessary to determine the optimal treatment strategy and timing of surgical intervention, especially for patients with proximal hematomas.
Journal ArticleDOI
Duration of Dual Antiplatelet Therapy After Implantation of Drug-Eluting Stents
Seung-Jung Park,Duk-Woo Park,Young-Hak Kim,Soo Jin Kang,Seung-Whan Lee,Cheol Whan Lee,Ki Hoon Han,Seong Wook Park,Sung Cheol Yun,Sang-Gon Lee,Seung-Woon Rha,In Whan Seong,Myung Ho Jeong,Seung Ho Hur,Nae Hee Lee,Junghan Yoon,Joo Young Yang,Bong Ki Lee,Young Jin Choi,Wook Sung Chung,Do-Sun Lim,Sang Sig Cheong,Kee Sik Kim,Jei Keon Chae,Deuk Young Nah,Doo-Soo Jeon,Ki Bae Seung,Jae-Sik Jang,Hun Sik Park,Keun Seok Lee +29 more
TL;DR: For example, the authors showed that the use of dual antiplatelet therapy for a period longer than 12 months in patients who had received drug-eluting stents was not significantly more effective than aspirin monotherapy in reducing the rate of myocardial infarction or death from cardiac causes.